华夏恒生生物科技ETF(QDII)(159892)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
39,689,751.42 |
126,732.27 |
14,314,994.72 |
145,059.39 |
存出保证金 |
- |
- |
15,443.77 |
216,913.73 |
交易性金融资产 |
4,287,701,799.90 |
4,149,817,838.09 |
2,640,306,449.37 |
2,833,491,210.54 |
其中:股票投资 |
4,206,196,815.82 |
4,149,817,838.09 |
2,640,306,449.37 |
2,833,491,210.54 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
30,441.00 |
- |
18,280.12 |
8,136,719.53 |
应收利息 |
- |
- |
- |
- |
应收股利 |
11,644,942.15 |
- |
13,600,872.68 |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
- |
- |
- |
资产总计 |
4,551,983,593.93 |
4,166,717,258.33 |
2,699,346,811.79 |
2,858,358,758.98 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
183,763,904.61 |
3,578.11 |
18,135,066.51 |
1,497.00 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
1,721,371.38 |
1,788,874.79 |
1,112,031.77 |
1,169,659.20 |
应付托管费 |
524,764.97 |
536,662.43 |
333,609.55 |
350,897.79 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
61,054,998.79 |
619,540.54 |
8,964,962.66 |
15,203,574.62 |
负债合计 |
247,065,039.75 |
2,948,655.87 |
28,545,670.49 |
16,725,628.61 |
所有者权益 |
实收基金 |
5,933,266,022.00 |
8,690,266,022.00 |
6,653,266,022.00 |
5,177,266,022.00 |
未分配利润 |
-1,628,347,467.82 |
-4,526,497,419.54 |
-3,982,464,880.70 |
-2,335,632,891.63 |
所有者权益合计 |
4,304,918,554.18 |
4,163,768,602.46 |
2,670,801,141.30 |
2,841,633,130.37 |
负债及所有者权益总计 |
4,551,983,593.93 |
4,166,717,258.33 |
2,699,346,811.79 |
2,858,358,758.98 |